Nalaganje...
Neoadjuvant endocrine therapy in breast cancer: current role and future perspectives
Luminal breast cancer, as defined by oestrogen and/or progesterone expression by immunohistochemistry, accounts for up to 75% of all breast cancers. In this population, endocrine therapy is likely to account for most of the gains obtained with the administration of adjuvant systemic treatment. The r...
Shranjeno v:
| izdano v: | Ecancermedicalscience |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Cancer Intelligence
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4720494/ https://ncbi.nlm.nih.gov/pubmed/26823678 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2016.609 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|